Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
Peripheral Neuropathy
Lancet 363:2151-2161, England,J.D. &Asbury,A.K., 2004
Recombinant Human Nerve Growth Factor in the Treatment of Diabetic Polyneuropathy
Neurol 51:695-702, 6621998., Apfel,S.C.,et al, 1998
Intravenous Immune Globulin Therapy for Neurologic Diseases
Ann Int Med 126:721-730, Dalakas,M.C., 1997
Nerve Growth Factor and Diabetic Neuropathy
Lancet 348:1044-1045, Dyck,P.J., 1996
The Effect of Intensive Diabetes Therapy on Development & Progression of Neuropathy
The Diabetes Control & Compl Trial Res Gr, Ann Int Med 122:561-56895., , 1995
Neuropathic Pain of Peripheral Origin:Advances in Pharmacologic Treatment
Neurol 45 (suppl 8) :s17-s25995., Galer,B.S., 1995
Nonvasculitic, Steroid-Responsive Mononeuritis Multiplex
Neurol 43:879-883, Logigian,E.L.,et al, 1993
"Chronic Sensory Demyelinating Neuropathy":CIDP Presenting as a Pure Sensory Neuropathy
JNNP 55:677-680, Oh,S.J.,et al, 1992
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Clin Characteristics, Course, & Diag Criteria
Arch Neurol 46:878-884, Barohn,R.J.,et al, 1989
Peripheral Neuropathy Associated with Monoclonal IgM Autoantibody
Ann Neurol 22:764-767, Steck,A.J.,et al, 1987
Osteosclerotic Myeloma & Peripheral Neuropathy
Neurol 33:202-210, Kelly,J.J.,et al, 1983